Final AER Guidance Requires Full Address, Recommends Prefatory Language
This article was originally published in The Tan Sheet
Executive Summary
In its final adverse event reports labeling guidance documents released Sept. 1, FDA does not budge on defining "domestic address" as a full mailing address, or on recommending labels include statements directing consumers how to submit AERs
You may also be interested in...
McCaskill Not Sold On Retailer Exemption From Supplement AER Filing
FDA regulations exempt retailers from compiling supplement adverse event reports, even for products that bear a store brand. Private label firms or contract manufacturers are required to receive AERs linked to those products and to forward reports of serious events to FDA within 15 days.
McCaskill Not Sold On Retailer Exemption From Supplement AER Filing
FDA regulations exempt retailers from compiling supplement adverse event reports, even for products that bear a store brand. Private label firms or contract manufacturers are required to receive AERs linked to those products and to forward reports of serious events to FDA within 15 days.
Supplement GMP Inspections Reveal Adverse Event Reports, Prompting Warning Letters
About 13% of the 156 warning letters FDA sent to dietary supplement firms from 2011 through June 2014 cited firms for failing to report serious adverse events or for not providing on product labels a domestic address or phone number at which to receive AERs. The citation total has climbed steadily from 2011.